Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype
Kazuhiko Takahashi, … , Tomoo Ishikawa, Hidehito Kotani
Kazuhiko Takahashi, … , Tomoo Ishikawa, Hidehito Kotani
Published December 15, 2002
Citation Information: J Clin Invest. 2002;110(12):1791-1799. https://doi.org/10.1172/JCI15784.
View: Text | PDF
Article Metabolism

Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype

  • Text
  • PDF
Abstract

Research Article

Authors

Kazuhiko Takahashi, Hiroaki Suwa, Tomoo Ishikawa, Hidehito Kotani

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
Metabolic marker changes and thioperamide activity. (a) Expression of UC...
Metabolic marker changes and thioperamide activity. (a) Expression of UCP genes in BAT, WAT, and skeletal muscle total RNA. Specific probes for each UCP were used, and GAPDH served as an internal control. Densitometry measurements on each band are shown as wild-type littermate control normalized by GAPDH. +/+, H3+/+ mice; –/–, H3–/– mice. (b) Thioperamide activity in H3+/+ and H3–/– mice in NPY-induced feeding. Thioperamide was administered intracerebroventricularly into 20- to 30-week-old male mice. Food intake was measured at 2-hour intervals in mice under ad libitum feeding conditions (n = 9, *P < 0.05). White bars indicate NPY/saline and black bars, NPY/thioperamide.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts